A comprehensive overview of role of combined myoinositol and D-chiroinositol (40:1 ratio) therapy in the management of PCOS

Journal Title: The New Indian Journal of OBGYN - Year 2019, Vol 5, Issue 2

Abstract

Polycystic Ovarian Syndrome (PCOS) is one of the most common metabolic and reproductive ailment among reproductive age group women. PCOS patients present with a constellation of signs and symptoms associated with menstrual dysfunction and androgen excess, which significantly impacts quality of life. Women with PCOS is at increased risk of various morbidities, which includes obesity, insulin resistance, type II diabetes mellitus, cardiovascular disease (CVD), infertility, cancer, and psychological disorders. Exact pathophysiology of PCOS is poorly understood although studies have suggested an important role of insulin resistance and/or resultant compensatory hyperinsulinemia. Deficiency in the usage and/or tissue availability of myoinositol (MI) and/or D-chiroinositol (DCI) in PCOS patients could likely lead to insulin resistance typical of this syndrome. Recent studies have demonstrated that combined supplement containing both MI + DCI in their physiological plasma ratio 40:1 is able to improve the endocrine profile, ovarian function and the insulin resistance in PCOS patients. The aim of the present review was to summarize currently available data on the MI+DCI (40:1) combination therapy in PCOS patients.

Authors and Affiliations

Abhijeet G Malvi, Alok Chaturvedi, Sonal V Mehta, Kishore R Sonkusare, Nilanj S Dave

Keywords

Related Articles

Non descent vaginal pan hysterectomy in benign ovarian tumour in elderly parous patients an experience

Objectives: 1) To study the feasibility of performing and outcome of vaginal hysterectomy in uteri without any descent and associated with benign ovarian tumour. 2) To compare the outcome of vaginal hysterectomy over hys...

C-reactive protein - as an early diagnostic marker of early onset sepsis and its correlation with blood culture

Objective: To document effects of intrapartum risk factors for early onset sepsis (EOS) on C-reactive protein (CRP) levels in neonates, and to assess the suitability of this test in diagnosing EOS and its correlation wit...

Low back ache in working women of reproductive age group in an urban area

Background - Back pain is a common complaint and is acknowledged as an important socioeconomic and health problem. Low back ache (LBA) not only leads to poor quality of life for individuals all over the world but also le...

Meconium stained amniotic fluid: A correlation with mode of delivery and perinatal outcome

Objectives: The aims of the study were to observe the modes of delivery and fetal outcome in meconium stain liquor. Methodology: This prospective observational study was done from June 2015 to June 2016. All the pregnant...

Screening for preeclampsia by urine albumin to creatinine ratio

Background: Proteinuria is a major component of preeclampsia. Urine protein measurement after 24 hour urine collection is the traditional standard method for the detection of proteinuria. It is time consuming. As an alte...

Download PDF file
  • EP ID EP641892
  • DOI 10.21276/obgyn.2019.5.2.2
  • Views 118
  • Downloads 0

How To Cite

Abhijeet G Malvi, Alok Chaturvedi, Sonal V Mehta, Kishore R Sonkusare, Nilanj S Dave (2019). A comprehensive overview of role of combined myoinositol and D-chiroinositol (40:1 ratio) therapy in the management of PCOS. The New Indian Journal of OBGYN, 5(2), 71-78. https://europub.co.uk/articles/-A-641892